Seeking Alpha

Celsion Corporation (CLSN)

  • BiotechX | Send Message 28 Oct

    When 1/4 of the $CLSN pipeline will be successful the company is a 10bagger.
    Reply (4)
  • View all 4 replies
    • Zizu_5 | Send Message 28 Oct
      : Me to, ph1 gen1 coming up nextyear that should be a nice catalyst, although dilution is worrying at this point...
    • BiotechX | Send Message 29 Oct
      : I remain optimistic, when I see the pipeline in clinics.
      • Bret Jensen | Send Message 13 Oct

        Celsion: A $2 Biotech Stock To Keep Your Eye On $CLSN
          • Kanak Kanti De | Send Message 9 Oct

            Premarket Biotech Digest: Valeant's "Buy And Raise" Deals, Celsion Undervalued, Verastem Slashes... $CLSN
              • Life Sciences Report | Send Message 30 Sep

                BTIG's Hartaj Singh's Advice For Biotech Investors: 'Hold Your Powder' 'Til Winter $CLSN, $CDTX, $EPRS
                  • Bret Jensen | Send Message 5 Sep

                    Celsion: A High Risk/High Reward $2 Biotech Concern $CLSN
                      • fidel george | Send Message 15 Jul

                        Pre market stock gainers: $VLTC, $RCPT, $CLSN, $OPGN, $ISIS, $CAR, $AXN, $NFLX, $OGXI, $CELG
                          • Kanak Kanti De | Send Message 28 May

                            Celsion's New Trial: How Does It Differ From The Old One? $CLSN
                              • Clinically Sound Investor | Send Message 18 Mar

                                Celsion Corporation Has Significant Upside In Q2 With An Unexpected Income Source $CLSN
                                  • PatrickTS | Send Message 23 Feb

                                    Research for 23.02: $AXN $CRMD $IBIO $CLSN $ARIA $THRX $CAPN
                                      • Clinically Sound Investor | Send Message 20 Nov 2014

                                        Celsion's Prospects For A Significant Upside Just Got A Lot Better $CLSN
                                          Company Description
                                          Celsion Corp is a fully-integrated oncology drug development company. The Company is engaged in developing a portfolio of cancer treatments, including directed chemotherapies, immunotherapies and RNA- or DNA-based therapies.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States